Modern drug discovery relies upon intelligent exploration of ‘in stock’ and ‘on demand’ virtual libraries of compounds. A comparative analysis highlights the explosive expansion of accessible chemical space and also reveals challenges and opportunities arising for computational drug discovery.
References
Wong, C. H. et al. Biostatistics 20, 273–286 (2019).
Wouters, O. J. et al. JAMA 323, 844–853 (2020).
Warr, W. A. et al. J. Chem. Inf. Model. 62, 2021–2034 (2022).
eMolecules. Introducing eXplore—a new trillion-sized chemical space by eMolecules; https://go.nature.com/3ULzKZC (2022).
Tingle, B. et al. Preprint at https://doi.org/10.26434/chemrxiv-2022-82czl (2022).
Cerón-Carrasco, J. P. ChemMedChem 17, e202200278 (2022).
Lowe, D. Virtual screening for coronavirus protease inhibitors: a waste of good electrons? https://go.nature.com/3PiHi52 (2022).
Lyu, J. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-022-01234-w (2022).
Ban, F. et al. J. Chem. Inf. Model. 57, 1018–1028 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Cherkasov, A. The ‘Big Bang’ of the chemical universe. Nat Chem Biol 19, 667–668 (2023). https://doi.org/10.1038/s41589-022-01233-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-022-01233-x
- Springer Nature America, Inc.